Biogen to Present New Research at the International Conference on Alzheimer’s and Parkinson’s…
CAMBRIDGE, Mass., March 11, 2022 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) announced the company will present new Alzheimer’s disease research, as well as data for ADUHELM® (aducanumab-avwa) injection 100 mg/mL for intravenous use,…